The researchers analyzed data from the REGARDS Study, which tracked cardiovascular-related outcomes in over 20,000 people for a decade, to identify adverse social determinants of health that can lead to a higher likelihood of a fatal heart attack.
Dr. Dadhania will be responsible for ensuring the operation and compliance of the transplant program, and will collaborate with NYP leadership to facilitate optimal care of transplant candidates and recipients.
Dr. Reisman will serve as Director of Structural Heart Disease at NYP/Weill Cornell Medicine and as Co-Director of Structural Heart Disease for NYP/Queens and NYP/Brooklyn Methodist Hospital.
In her role as Executive Director of the NYCEA, Ms. Rachmuth will oversee a large staff of experts in in the fields of elder abuse research, advocacy, and clinical service.
